Table 1.

Tabulation of posterior probabilities of treatment benefit and posterior probabilities of differential treatment effect for patients in the SOLVD trials

	SOLVD Treatment Trial	SOLVD Prevention Trial
	51.38	20.47
	24.69	23.71
	20.08	41.98
	3.85	13.84
	0.00	0.00
	19.36	7.30
	41.93	31.58

For each trial, the empirical percentage of patients whose estimated posterior probability of treatment benefit lies within each of the intervals , and is reported. In addition, the percentages of patients in each trial that exhibit “strong” (i.e. ) and “mild” (i.e. ) evidence of differential treatment effect are shown.